Proteomic analysis of urine in patients with intestinal segments transposed into the urinary tract

Ghulam Nabi, James Michael Olu N'Dow, S. T. Hassan, Ian Rylance Booth, Phillip Cash

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Intestinal segments are used to replace or reconstruct the urinary bladder when it has become dysfunctional or develops life-threatening disease such as cancer. The quality of life in patients with intestinal segments used to either enlarge or completely replace the native bladder is adversely affected by recurrent urinary tract infections, excessive mucus production and the occasional development of malignancy. At present, there is no reliable method of predicting or noninvasively monitoring these patients for the development of these complications. The characterisation of proteins secreted into urine from the transposed intestinal segments could serve as important indicators of these clinical complications. Urine is an ideal source of material in which to search for biomarkers, since it bathes the affected tissues and can be obtained relatively easily by noninvasive methods. The urinary proteome of patients with intestinal segments transposed into the urinary tract is unknown and we present the first global description of the urinary protein profile in these patients. Sample preparation is a critical step in achieving accurate and reliable data. We describe a method to prepare urinary proteins that was compatible with their subsequent analysis using two-dimensional polyacrylamide gel electrophoresis. This method helped to overcome some of the technical problems encountered in analysing urine from this patient cohort. The method was used to analyse urinary proteins recovered from five healthy controls and ten patients with intestinal segments transposed into the urinary tract. Four low molecular weight proteins were found to be present in nine out of ten for the patient group but for none of the healthy controls. The four proteins were identified as lithostathine-1 alpha precursor, pancreatitis associated protein-1 precursor, liver fatty acid binding protein and testis expressed protein-12. The role of these proteins as potential biomarkers of intestinal cell activity within the reconstructed bladder is discussed.

Original languageEnglish
Pages (from-to)1729-1733
Number of pages4
JournalProteomics
Volume5
Issue number6
Early online date14 Mar 2005
DOIs
Publication statusPublished - Apr 2005

Keywords

  • body fluids
  • protein biomarker
  • two-dimensional gel electrophoresis
  • urinary proteome
  • 2-DIMENSIONAL GEL-ELECTROPHORESIS
  • pancreatic ductal adenocarcinoma
  • regenerating gene family
  • protein
  • expression
  • bowel
  • reconstruction
  • disease

Cite this

Proteomic analysis of urine in patients with intestinal segments transposed into the urinary tract. / Nabi, Ghulam; N'Dow, James Michael Olu; Hassan, S. T.; Booth, Ian Rylance; Cash, Phillip.

In: Proteomics, Vol. 5, No. 6, 04.2005, p. 1729-1733.

Research output: Contribution to journalArticle

Nabi, Ghulam ; N'Dow, James Michael Olu ; Hassan, S. T. ; Booth, Ian Rylance ; Cash, Phillip. / Proteomic analysis of urine in patients with intestinal segments transposed into the urinary tract. In: Proteomics. 2005 ; Vol. 5, No. 6. pp. 1729-1733.
@article{94b463a196964312899ce25a2e054591,
title = "Proteomic analysis of urine in patients with intestinal segments transposed into the urinary tract",
abstract = "Intestinal segments are used to replace or reconstruct the urinary bladder when it has become dysfunctional or develops life-threatening disease such as cancer. The quality of life in patients with intestinal segments used to either enlarge or completely replace the native bladder is adversely affected by recurrent urinary tract infections, excessive mucus production and the occasional development of malignancy. At present, there is no reliable method of predicting or noninvasively monitoring these patients for the development of these complications. The characterisation of proteins secreted into urine from the transposed intestinal segments could serve as important indicators of these clinical complications. Urine is an ideal source of material in which to search for biomarkers, since it bathes the affected tissues and can be obtained relatively easily by noninvasive methods. The urinary proteome of patients with intestinal segments transposed into the urinary tract is unknown and we present the first global description of the urinary protein profile in these patients. Sample preparation is a critical step in achieving accurate and reliable data. We describe a method to prepare urinary proteins that was compatible with their subsequent analysis using two-dimensional polyacrylamide gel electrophoresis. This method helped to overcome some of the technical problems encountered in analysing urine from this patient cohort. The method was used to analyse urinary proteins recovered from five healthy controls and ten patients with intestinal segments transposed into the urinary tract. Four low molecular weight proteins were found to be present in nine out of ten for the patient group but for none of the healthy controls. The four proteins were identified as lithostathine-1 alpha precursor, pancreatitis associated protein-1 precursor, liver fatty acid binding protein and testis expressed protein-12. The role of these proteins as potential biomarkers of intestinal cell activity within the reconstructed bladder is discussed.",
keywords = "body fluids, protein biomarker, two-dimensional gel electrophoresis, urinary proteome, 2-DIMENSIONAL GEL-ELECTROPHORESIS, pancreatic ductal adenocarcinoma, regenerating gene family, protein, expression, bowel, reconstruction, disease",
author = "Ghulam Nabi and N'Dow, {James Michael Olu} and Hassan, {S. T.} and Booth, {Ian Rylance} and Phillip Cash",
year = "2005",
month = "4",
doi = "10.1002/pmic.200401125",
language = "English",
volume = "5",
pages = "1729--1733",
journal = "Proteomics",
issn = "1615-9853",
publisher = "John Wiley & Sons, Ltd",
number = "6",

}

TY - JOUR

T1 - Proteomic analysis of urine in patients with intestinal segments transposed into the urinary tract

AU - Nabi, Ghulam

AU - N'Dow, James Michael Olu

AU - Hassan, S. T.

AU - Booth, Ian Rylance

AU - Cash, Phillip

PY - 2005/4

Y1 - 2005/4

N2 - Intestinal segments are used to replace or reconstruct the urinary bladder when it has become dysfunctional or develops life-threatening disease such as cancer. The quality of life in patients with intestinal segments used to either enlarge or completely replace the native bladder is adversely affected by recurrent urinary tract infections, excessive mucus production and the occasional development of malignancy. At present, there is no reliable method of predicting or noninvasively monitoring these patients for the development of these complications. The characterisation of proteins secreted into urine from the transposed intestinal segments could serve as important indicators of these clinical complications. Urine is an ideal source of material in which to search for biomarkers, since it bathes the affected tissues and can be obtained relatively easily by noninvasive methods. The urinary proteome of patients with intestinal segments transposed into the urinary tract is unknown and we present the first global description of the urinary protein profile in these patients. Sample preparation is a critical step in achieving accurate and reliable data. We describe a method to prepare urinary proteins that was compatible with their subsequent analysis using two-dimensional polyacrylamide gel electrophoresis. This method helped to overcome some of the technical problems encountered in analysing urine from this patient cohort. The method was used to analyse urinary proteins recovered from five healthy controls and ten patients with intestinal segments transposed into the urinary tract. Four low molecular weight proteins were found to be present in nine out of ten for the patient group but for none of the healthy controls. The four proteins were identified as lithostathine-1 alpha precursor, pancreatitis associated protein-1 precursor, liver fatty acid binding protein and testis expressed protein-12. The role of these proteins as potential biomarkers of intestinal cell activity within the reconstructed bladder is discussed.

AB - Intestinal segments are used to replace or reconstruct the urinary bladder when it has become dysfunctional or develops life-threatening disease such as cancer. The quality of life in patients with intestinal segments used to either enlarge or completely replace the native bladder is adversely affected by recurrent urinary tract infections, excessive mucus production and the occasional development of malignancy. At present, there is no reliable method of predicting or noninvasively monitoring these patients for the development of these complications. The characterisation of proteins secreted into urine from the transposed intestinal segments could serve as important indicators of these clinical complications. Urine is an ideal source of material in which to search for biomarkers, since it bathes the affected tissues and can be obtained relatively easily by noninvasive methods. The urinary proteome of patients with intestinal segments transposed into the urinary tract is unknown and we present the first global description of the urinary protein profile in these patients. Sample preparation is a critical step in achieving accurate and reliable data. We describe a method to prepare urinary proteins that was compatible with their subsequent analysis using two-dimensional polyacrylamide gel electrophoresis. This method helped to overcome some of the technical problems encountered in analysing urine from this patient cohort. The method was used to analyse urinary proteins recovered from five healthy controls and ten patients with intestinal segments transposed into the urinary tract. Four low molecular weight proteins were found to be present in nine out of ten for the patient group but for none of the healthy controls. The four proteins were identified as lithostathine-1 alpha precursor, pancreatitis associated protein-1 precursor, liver fatty acid binding protein and testis expressed protein-12. The role of these proteins as potential biomarkers of intestinal cell activity within the reconstructed bladder is discussed.

KW - body fluids

KW - protein biomarker

KW - two-dimensional gel electrophoresis

KW - urinary proteome

KW - 2-DIMENSIONAL GEL-ELECTROPHORESIS

KW - pancreatic ductal adenocarcinoma

KW - regenerating gene family

KW - protein

KW - expression

KW - bowel

KW - reconstruction

KW - disease

U2 - 10.1002/pmic.200401125

DO - 10.1002/pmic.200401125

M3 - Article

VL - 5

SP - 1729

EP - 1733

JO - Proteomics

JF - Proteomics

SN - 1615-9853

IS - 6

ER -